[1]
Seren, O.T. et al. 2026. Dupilumab after sequential omalizumab and benralizumab failure in T2-high asthma–COPD overlap: A case report. Allergologia et Immunopathologia. 54, 3 (May 2026), 180–183. DOI:https://doi.org/10.15586/aei.v54i3.1566.